{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:01:32Z","timestamp":1792094492401,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.tcm.2025.02.001","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:05:55Z","timestamp":1739300755000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiac implantable electronic device infection"],"prefix":"10.1016","volume":"35","author":[{"given":"Simon","family":"Christie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.tcm.2025.02.001_bib0001","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jacc.2019.09.060","article-title":"Risk factors for infections involving cardiac implanted electronic devices","volume":"74","author":"Birnie","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.tcm.2025.02.001_bib0002","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.114.009081","article-title":"Rates of and factors associated with infection in 200909 medicare implantable cardioverter-defibrillator implants: results from the national cardiovascular data registry","volume":"130","author":"Prutkin","year":"2014","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.tcm.2025.02.001_bib0003","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/eurheartj\/ehz316","article-title":"Incidence of device-related infection in 97750 patients: clinical data from the complete Danish device-cohort (1982-2018)","volume":"40","author":"Olsen","year":"2019","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.tcm.2025.02.001_bib0004","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tcm.2025.02.001_bib0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/europace\/euz246","volume":"22","author":"Blomstrom-Lundqvist","year":"2020","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.tcm.2025.02.001_bib0006","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jamacardio.2023.3379","article-title":"Lead extraction and mortality among patients with cardiac implanted electronic device infection","volume":"8","author":"Pokorney","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2025.02.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae169","article-title":"Chronic kidney disease and transvenous cardiac implantable electronic device infection-is there an impact on healthcare utilization, costs, disease progression, and mortality?","volume":"26","author":"Wright","year":"2024","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.001_bib0008","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13756-023-01347-4","article-title":"The economic burden of cardiac implantable electronic device infections in Alberta, Canada: a population-based study using validated administrative data","volume":"12","author":"Rennert-May","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008280","article-title":"Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT trial","volume":"13","author":"Wilkoff","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.003929","article-title":"Incidence, treatment intensity, and incremental annual expenditures for patients experiencing a cardiac implantable electronic device infection: evidence from a large US payer database 1-year post implantation","volume":"9","author":"Sohail","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.001_bib0011","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jamacardio.2023.0467","article-title":"Association of the timing and extent of cardiac implantable electronic device infections with mortality","volume":"8","author":"Han","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"24","key":"10.1016\/j.tcm.2025.02.001_bib0012","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.jacc.2018.09.068","article-title":"Prevention of arrhythmia device infection trial: the PADIT trial","volume":"72","author":"Krahn","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.tcm.2025.02.001_bib0013","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","article-title":"16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008","volume":"58","author":"Greenspon","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.001_bib0014","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/eurheartj\/ehq497","article-title":"Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients","volume":"32","author":"Johansen","year":"2011","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.001_bib0015","doi-asserted-by":"crossref","first-page":"ofac547","DOI":"10.1093\/ofid\/ofac547","article-title":"Forty-year trends in cardiac implantable electronic device infective endocarditis","volume":"9","author":"Hernandez-Meneses","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.001_bib0016","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.hrthm.2017.03.019","article-title":"Cardiac implantable electronic device infections: who is at greatest risk?","volume":"14","author":"Joy","year":"2017","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.001_bib0017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hroo.2023.12.002","article-title":"Adherent skin barrier drape use is associated with a reduced risk of cardiac implantable device infection: results from a prospective study of 14,225 procedures","volume":"5","author":"Golian","year":"2024","journal-title":"Heart Rhythm O2"},{"issue":"20","key":"10.1016\/j.tcm.2025.02.001_bib0018","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1901111","article-title":"Antibacterial envelope to prevent cardiac implantable device infection","volume":"380","author":"Tarakji","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.tcm.2025.02.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.123.012446","article-title":"The BLISTER score: a novel, externally validated tool for predicting cardiac implantable electronic device infections, and its cost-utility implications for antimicrobial envelope use","volume":"17","author":"Maclean","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.001_bib0020","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1161\/CIR.0000000000001187","article-title":"Update on cardiovascular implantable electronic device infections and their prevention, diagnosis, and management: a scientific statement from the American Heart Association: endorsed by the international society for cardiovascular infectious diseases","volume":"149","author":"Baddour","year":"2024","journal-title":"Circulation"},{"issue":"23 Suppl 4","key":"10.1016\/j.tcm.2025.02.001_bib0021","doi-asserted-by":"crossref","first-page":"iv3","DOI":"10.1093\/europace\/euab042","article-title":"Epidemiology of cardiac implantable electronic device infections: incidence and risk factors","volume":"23","author":"Han","year":"2021","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.001_bib0022","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2459\/JCM.0000000000000797","article-title":"Prevalence and prognosis of lead masses in patients with cardiac implantable electronic devices without infection","volume":"20","author":"Golzio","year":"2019","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.001_bib0023","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1540-8159.2011.03034.x","article-title":"Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography","volume":"34","author":"Downey","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.001_bib0024","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/cer-2017-0080","article-title":"Incidence and costs of cardiac device infections: retrospective analysis using German health claims data","volume":"7","author":"Ludwig","year":"2018","journal-title":"J Comp Eff Res"},{"issue":"18","key":"10.1016\/j.tcm.2025.02.001_bib0025","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1161\/01.CIR.97.18.1791","article-title":"Role of the preaxillary flora in pacemaker infections: a prospective study","volume":"97","author":"Da","year":"1998","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.tcm.2025.02.001_bib0026","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2007.01.072","article-title":"Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections","volume":"49","author":"Sohail","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.001_bib0027","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-199411000-00003","article-title":"Pacemaker endocarditis. Report of 44 cases and review of the literature","volume":"73","author":"Arber","year":"1994","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.001_bib0028","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.hrthm.2010.05.016","article-title":"Cardiac implantable electronic device infections: presentation, management, and patient outcomes","volume":"7","author":"Tarakji","year":"2010","journal-title":"Heart Rhythm"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.001_bib0029","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2016.01.009","article-title":"Clinically significant pocket hematoma increases long-term risk of device infection: bruise control infection study","volume":"67","author":"Essebag","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2025.02.001_bib0030","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.hrthm.2021.07.011","article-title":"Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: a WRAP-IT trial analysis","volume":"18","author":"Tarakji","year":"2021","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.001_bib0031","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/europace\/euv053","article-title":"Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis","volume":"17","author":"Polyzos","year":"2015","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.001_bib0032","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.hroo.2022.05.012","article-title":"Risk factors for hematoma in patients undergoing cardiac device procedures: a WRAP-IT trial analysis","volume":"3","author":"Tarakji","year":"2022","journal-title":"Heart Rhythm O2"},{"issue":"4","key":"10.1016\/j.tcm.2025.02.001_bib0033","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/cid\/ciad271","article-title":"The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: updating the modified Duke criteria","volume":"77","author":"Fowler","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.tcm.2025.02.001_bib0034","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for Healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.001_bib0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/JCM.02230-12","article-title":"Sonication of explanted cardiac implants improves microbial detection in cardiac device infections","volume":"51","author":"Oliva","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.001_bib0036","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1540-8159.2007.00574.x","article-title":"Pacemaker endocarditis: clinical features and management of 60 consecutive cases","volume":"30","author":"Massoure","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.001_bib0037","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/hrt.81.1.82","article-title":"Pacemaker lead infection: echocardiographic features, management, and outcome","volume":"81","author":"Victor","year":"1999","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.001_bib0038","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/cid\/ciaa472","article-title":"Discriminative ability and reliability of transesophageal echocardiography in characterizing cases of cardiac device lead vegetations versus noninfectious echodensities","volume":"72","author":"George","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.tcm.2025.02.001_bib0039","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12350-017-1063-0","article-title":"Role of (18)F-FDG PET\/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis","volume":"26","author":"Mahmood","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"10","key":"10.1016\/j.tcm.2025.02.001_bib0040","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jcmg.2013.08.001","article-title":"Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections","volume":"6","author":"Erba","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.001_bib0041","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.hrthm.2011.05.015","article-title":"Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections","volume":"8","author":"Le","year":"2011","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.tcm.2025.02.001_bib0042","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2023.02.042","article-title":"Low utilization of lead extraction among patients with infective endocarditis and implanted cardiac electronic devices","volume":"81","author":"Sciria","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"10.1016\/j.tcm.2025.02.001_bib0043","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/eurheartj\/ehx080","article-title":"The European Lead extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of transvenous lead extraction outcomes","volume":"38","author":"Bongiorni","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.tcm.2025.02.001_bib0044","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2022.10.022","article-title":"Regional antibiotic delivery for implanted cardiovascular electronic device infections","volume":"81","author":"Topaz","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.001_bib0045","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.hrthm.2017.01.035","article-title":"Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study","volume":"14","author":"Duray","year":"2017","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.tcm.2025.02.001_bib0046","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.hrthm.2017.05.017","article-title":"A leadless pacemaker in the real-world setting: the Micra Transcatheter Pacing System Post-Approval Registry","volume":"14","author":"Roberts","year":"2017","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.tcm.2025.02.001_bib0047","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/pace.13752","article-title":"Incidence and outcomes of systemic infections in patients with leadless pacemakers: data from the Micra IDE study","volume":"42","author":"El-Chami","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.001_bib0048","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00392-015-0929-x","article-title":"Complete encapsulation of a leadless cardiac pacemaker","volume":"105","author":"Kypta","year":"2016","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2025.02.001_bib0049","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacep.2016.02.014","article-title":"MICRA leadless pacemaker on autopsy","volume":"2","author":"Vamos","year":"2016","journal-title":"JACC Clin Electrophysiol."},{"issue":"2","key":"10.1016\/j.tcm.2025.02.001_bib0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacep.2018.12.008","article-title":"Leadless pacemaker implantation in hemodialysis patients: experience with the Micra transcatheter pacemaker","volume":"5","author":"El-Chami","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.001_bib0051","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.tcm.2025.02.001_bib0052","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.hrthm.2022.07.031","article-title":"Infection in patients with subcutaneous implantable cardioverter-defibrillator: results of the S-ICD Post Approval study","volume":"19","author":"Gold","year":"2022","journal-title":"Heart Rhythm"},{"issue":"16","key":"10.1016\/j.tcm.2025.02.001_bib0053","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.001_bib0054","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacep.2021.08.009","article-title":"Risk factors for CIED infection after secondary procedures: insights from the WRAP-IT trial","volume":"8","author":"Tarakji","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"22","key":"10.1016\/j.tcm.2025.02.001_bib0055","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"368","author":"Birnie","year":"2013","journal-title":"N Engl J Med"},{"issue":"44","key":"10.1016\/j.tcm.2025.02.001_bib0056","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","article-title":"Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)","volume":"39","author":"Birnie","year":"2018","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.tcm.2025.02.001_bib0057","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/CIRCULATIONAHA.106.678664","article-title":"Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study","volume":"116","author":"Klug","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.001_bib0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCEP.108.795906","article-title":"Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial","volume":"2","author":"de Oliveira","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"18","key":"10.1016\/j.tcm.2025.02.001_bib0059","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.CIR.97.18.1796","article-title":"Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis","volume":"97","author":"Da","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.001_bib0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJMoa0810988","article-title":"Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis","volume":"362","author":"Darouiche","year":"2010","journal-title":"N Engl J Med"},{"issue":"10008","key":"10.1016\/j.tcm.2025.02.001_bib0061","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0140-6736(15)00244-5","article-title":"Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial","volume":"386","author":"Mimoz","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.tcm.2025.02.001_bib0062","article-title":"Preoperative hair removal to reduce surgical site infection","author":"Tanner","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.tcm.2025.02.001_bib0063","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jval.2020.12.021","article-title":"Cost-effectiveness analyses of an absorbable antibacterial envelope for use in patients at increased risk of cardiac implantable electronic device infection in Germany, Italy, and England","volume":"24","author":"Boriani","year":"2021","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.tcm.2025.02.001_bib0064","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad159","article-title":"Cost-effectiveness of an antibacterial envelope for infection prevention in patients undergoing cardiac resynchronization therapy reoperations in Denmark","volume":"25","author":"Frausing","year":"2023","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.tcm.2025.02.001_bib0065","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.hrthm.2023.08.015","article-title":"Chlorhexidine gluconate pocket lavage to prevent cardiac implantable electronic device infection in high-risk procedures","volume":"20","author":"Diaz","year":"2023","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.tcm.2025.02.001_bib0066","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad306","article-title":"Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection","volume":"25","author":"Borov","year":"2023","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.tcm.2025.02.001_bib0067","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s13019-024-03059-1","article-title":"Taurolidine-containing solution for reducing cardiac implantable electronic device infection-early report from the European TauroPace registry","volume":"19","author":"Vonthein","year":"2024","journal-title":"J Cardiothorac Surg"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173825000210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173825000210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T18:53:06Z","timestamp":1760640786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173825000210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1050173825000210"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2025.02.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac implantable electronic device infection","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2025.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}